These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 32710901)
21. Luteolin-7-O-glucoside protects dopaminergic neurons by activating estrogen-receptor-mediated signaling pathway in MPTP-induced mice. Qin L; Chen Z; Yang L; Shi H; Wu H; Zhang B; Zhang W; Xu Q; Huang F; Wu X Toxicology; 2019 Oct; 426():152256. PubMed ID: 31381935 [TBL] [Abstract][Full Text] [Related]
22. IGF-1 inhibits MPTP/MPP Wang XW; Yuan LJ; Yang Y; Zhang M; Chen WF Am J Physiol Endocrinol Metab; 2020 Oct; 319(4):E734-E743. PubMed ID: 32865008 [TBL] [Abstract][Full Text] [Related]
23. Deletion of autophagy-related gene 7 in dopaminergic neurons prevents their loss induced by MPTP. Niu XY; Huang HJ; Zhang JB; Zhang C; Chen WG; Sun CY; Ding YQ; Liao M Neuroscience; 2016 Dec; 339():22-31. PubMed ID: 27693472 [TBL] [Abstract][Full Text] [Related]
24. Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease. Zheng M; Liu C; Fan Y; Yan P; Shi D; Zhang Y Neuropharmacology; 2017 Apr; 116():412-420. PubMed ID: 28093210 [TBL] [Abstract][Full Text] [Related]
26. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease. Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease. Pupyshev AB; Tikhonova MA; Akopyan AA; Tenditnik MV; Dubrovina NI; Korolenko TA Pharmacol Biochem Behav; 2019 Feb; 177():1-11. PubMed ID: 30582934 [TBL] [Abstract][Full Text] [Related]
29. The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's Disease. Haque ME; Azam S; Akther M; Cho DY; Kim IS; Choi DK Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925146 [TBL] [Abstract][Full Text] [Related]
30. Vanillin Mitigates the MPTP-Induced α-Synucleinopathy in a Mouse Model of Parkinson's Disease: Insights into the Involvement of Wnt/β-Catenin Signaling. Rani L; Mondal AC J Integr Neurosci; 2024 Sep; 23(9):175. PubMed ID: 39344237 [TBL] [Abstract][Full Text] [Related]
31. Vitexin protects dopaminergic neurons in MPTP-induced Parkinson's disease through PI3K/Akt signaling pathway. Hu M; Li F; Wang W Drug Des Devel Ther; 2018; 12():565-573. PubMed ID: 29588573 [TBL] [Abstract][Full Text] [Related]
32. Papaverine inhibits α-synuclein aggregation by modulating neuroinflammation and matrix metalloproteinase-3 expression in the subacute MPTP/P mouse model of Parkinson's disease. Leem YH; Park JS; Park JE; Kim DY; Kang JL; Kim HS Biomed Pharmacother; 2020 Oct; 130():110576. PubMed ID: 32768884 [TBL] [Abstract][Full Text] [Related]
33. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease. Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935 [TBL] [Abstract][Full Text] [Related]
34. Treadmill Exercise Attenuates α-Synuclein Levels by Promoting Mitochondrial Function and Autophagy Possibly via SIRT1 in the Chronic MPTP/P-Induced Mouse Model of Parkinson's Disease. Koo JH; Cho JY Neurotox Res; 2017 Oct; 32(3):473-486. PubMed ID: 28656548 [TBL] [Abstract][Full Text] [Related]
35. Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor. Komnig D; Dagli TC; Habib P; Zeyen T; Schulz JB; Falkenburger BH J Neurochem; 2018 Dec; 147(5):678-691. PubMed ID: 30152864 [TBL] [Abstract][Full Text] [Related]
36. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress. Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450 [TBL] [Abstract][Full Text] [Related]
37. Dopamine neuron loss by selective deletion of autophagy-related gene 5 is not exacerbated by MPTP toxicity in midbrain. Ren YH; Niu XY; Huang HJ; Hao XD; Wang PX; Chi YL; Ding YQ; Liao M Neurosci Lett; 2018 May; 675():140-144. PubMed ID: 29175031 [TBL] [Abstract][Full Text] [Related]
38. Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice. Smeyne RJ; Breckenridge CB; Beck M; Jiao Y; Butt MT; Wolf JC; Zadory D; Minnema DJ; Sturgess NC; Travis KZ; Cook AR; Smith LL; Botham PA PLoS One; 2016; 11(10):e0164094. PubMed ID: 27788145 [TBL] [Abstract][Full Text] [Related]
39. Kaemperfol Protects Dopaminergic Neurons by Promoting mTOR-Mediated Autophagy in Parkinson's Disease Models. Liu Z; Zhuang W; Cai M; Lv E; Wang Y; Wu Z; Wang H; Fu W Neurochem Res; 2023 May; 48(5):1395-1411. PubMed ID: 36469163 [TBL] [Abstract][Full Text] [Related]
40. c-Jun/Bim Upregulation in Dopaminergic Neurons Promotes Neurodegeneration in the MPTP Mouse Model of Parkinson's Disease. Hu K; Huang Q; Liu C; Li Y; Liu Y; Wang H; Li M; Ma S Neuroscience; 2019 Feb; 399():117-124. PubMed ID: 30590105 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]